IFNG and rheumatic disorder: Therefore, since 2009, Danish guidelines have recommended systematic screening by interferon gamma release assays (IGRA) for TBI regardless of exposure to M. tuberculosis before initiation of biological agents to treat inflammatory bowel disease (IBD) and rheumatic disease (IRD) [11].